lactate and fhydroxybutyrate, lower than expected levels of acetoacetate and dicarboxylic acids, and the presence of several other metabolites suggesting a disturbed citric acid cycle and redox state. Thus, the defect in this patient may be more widespread than is apparent from the clinical presentation.
Abbreviations CNS, central nervous system CK, creatine kinase EMG, electromyogram ECG, electrocardiogram MCT, medium chain triglyceride SDS, sodium dodecyl sulfate DCIP, 2,6-dichloroindophenol A number of distinct hereditary defects of mitochondrial function in muscle have been reported in patients with myopathy. The major function of mitochondria is to provide energy in the form of ATP or creatine phosphate which enables cells to perform a variety of essential functions. The defects which impinge directly on energy metabolism can be divided into four major categories: 1) defects of the carnitine acylcarnitine transport system (muscle carnitine deficiency, systemic carnitine deficiency, carnitine palmitoyltransferase deficiency); 2) defects of mitochondrial matrix enzymes including pyruvate carboxylase, malic enzyme, the pyruvate dehydrogenase complex (pyruvate decarboxylase deficiency, dihydrolipoyl dehydrogenase deficiency, pyruvate dehydrogenase phosphatase deficiency, and possibly dihydrolipoyl transacetylase deficiency), and defects of the tricarboxylic acid cycle (a-ketoglutarate dehydrogenase), or fatty acid degradation; 3) defects of the electron transport chain (deficient oxidation of NADH, cytochrome h deficiency, cytochrome c oxidase (aa3) deficiency, and combined cytochrome deficiencies (aa3 + h): and 4) defects of energy conservation and transduction (hypermetabolic myopathy or Lufts disease, other mitochondrial myopathies with "loose coupling" and mitochondrial ATPase deficiency).
Many of these disorders are classified as "mitochondrial myopathies," a term which implies a myopathic process associated with abnormalities in the number, size, shape, or structure of the mitochondria, evident on microscopic examination. In some of these myopathies, the histological changes may be quite minor; in others, aggregates of mitochondria, occumng in the subsarcolemmal area of the cell, give rise to the so-called ragged red fibers seen with the modified Gomori trichrome stain. Intense staining of these aggregates for succinic dehydrogenase, NADHtetrazolium reductase, or cytochrome oxidase activities confirms their mitochondrial origin. On electron microscopy, the mitochondria are often very bizarre with densely packed cristae or paracrystalline inclusions.
Not all mitochondrial myopathies are primary defects of mitochondrial function (1 3) and, conversely, some hereditary defects of mitochondria do not produce a typical mitochondrial myopathy. For example, in systemic or muscle carnitine deficiency, the histological findings are generally those of a lipid storage myopathy (17, 24, 30) ; in defects of carnitine palmitoyltransferase, pyruvate carboxylase or the pyruvate dehydrogenase complex, the morphological changes in muscle may be slight or even undetectable (30) . In several of the mitochondrial deficiencies, tissues other than skeletal muscle may be involved. Examples are the cardiomyopathy associated with muscle carnitine deficiency (21) , or the renal Fanconi syndrome described in several patients with cytochrome c oxidase deficiency (14, 43, 47) . Involvement of the CNS also occurs in many of these conditions and may cause overwhelming clinical disease. For example, some patients with disorders of the pyruvate dehydrogenase complex present with hypotonia, progressive encephalop athy, and lactic acidosis, often resulting in death in early infancy
(1 1, 37, 38, 45) . Patients with less severe defects of this system have a much milder phenotype with intermittent ataxia and minimal lactic acidosis (23) . Severe lactic acidosis is frequent in patients with pyruvate carboxylase deficiency (2, 22, 39, 48) and mild to severe lactic acidosis is found in defects of the respiratory chain (14, 25, 26, (31) (32) (33) 40, 43, 47, 49) .
The proteins of the inner mitochondrial membrane which comprise the respiratory chain exist as a series of well defined complexes. These are referred to as complex I (NADH-ubiquinone reductase), complex I1 (succinate-ubiquinone reductase), complex I11 (ubiquinol-cytochrome c oxidoreductase), and complex IV (cytochrome c oxidase). Each complex contains several distinct polypeptides and two or more redox sites (3, 8, 36) . These complexes are embedded in the inner mitochondrial membrane and mediate the passage of electrons to molecular oxygen. The seauence of reactions which they catalyze is shown in Figure   1 . he' energy which is generated-from -electron transport is conserved as a proton and electrochemical gradient at three coupling sites, located in complexes I, 111, and IV. The proton gradient is utilized for ion transport or for the synthesis of ATP (complex V). Several patients have been described with defects in the electron transport chain. The sites of these defects have generally been identified by studies of oxygen consumption in the presence of various substrates or by spectral analysis of the cytochromes. More recently, measurements of enzyme activities have helped to localize the sites of these deficiencies (14, 26, 33, 43, 47, 49) . However, in no case were the individual polypeptides of complexes I-IV examined, so that the primary lesion in these patients is not known.
Here we report studies on a patient with progressive muscle weakness, mitochondrial myopathy, and lactic acidosis with low levels of reducible cytochrome h and deficient activity of ubiquinol-cytochrome c reductase (complex 111) in isolated muscle mitochondria. Examination of the individual polypeptides of complex 111 with the aid of specific antibodies has shown that, in addition to reducible cytochrome h, several other polypeptides were deficient.
CASE REPORT
Our patient, a 17-year-old girl of Blackfoot Indian, Jewish, and European ancestry, was the product of a normal gestation and birth. She was completely asymptomatic and fully active until age 9 when decreased exercise tolerance was noted. This was attributed to multiple ventricular extrasystoles that developed on minor exertion. Her height and weight, which at 7 years had been in the 50th percentile, had fallen to the loth percentile.
At 10 years, exercise tolerance was worse; muscle cramps and vomiting developed after exercise but muscle weakness was not noted at rest. ECG showed sinus bigeminy for which she received propranolol. Echocardiography was normal and her symptoms were attributed to mild obstructive lung disease. Metabolic acidosis was present but was not investigated.
By 15 years of age, the patient developed severe dyspnea after walking only 100-200 m. This was frequently accompanied by leg cramps but no change in urine color. On examination, height and weight were at the loth percentile. There was diffuse muscle wasting and marked weakness of all muscle groups. Examination of the heart, eyes, and central nervous system was normal. Laboratory values included normal blood urea nitrogen, creatinine, glutamate oxalacetic transaminase, alkaline phosphatase, thyroid function tests and immunologic tests. The CK was 356 IU (n = 10-200 IU). EMG showed a myopathic picture. Urinalysis showed a trace of protein and some ketones. Systemic acidosis with an anion gap of 17-28 was evident. Prior to an exercise test on a treadmill, the serum lactate was 3.4 mEq/liter; within 3 min her pulse rate was 160 and she was exhausted. At that stage, the pH was 7.2 and serum lactate was 13.2 mEq/liter; the CK did not rise. Histochemical examination of muscle showed a ragged red fiber myopathy with degenerating and regenerating fibers, and electron microscopy revealed abnormal mitochondria with crystalline structures within them. The glycogen and fat content of the cells was increased.
Between the age of 15 and 17 years, the patient's tolerance for exercise became even more limited so that she missed most of one school year. At 17 years, she had an episode of severe metabolic acidosis resulting in prolonged vomiting and a seizure; the serum lactate was 18.2 mEq/liter. Since then, she has been taking sodium bicarbonate, 300 mEq/day. This has helped to control the acidosis but the serum lactate has remained elevated, ranging from 3-13.2 mEq/liter. Blood pyruvate on two occasions was 1.6 and 3.2 mg/dl (normal, 0.3-0.9 mg/dl). The lactate/ pyruvate ratio was also elevated, 26 and 29 (normal < 20). Serum amino acids were normal, except alanine which was 0.76 rmol/ ml (normal, 0.21-0.66 pmol/ml). Urine amino acid chromatography also showed a slight elevation of alanine. Gas chromatography of organic acids in two random urine samples showed greatly increased lactate and 2-hydroxybutyrate, a small peak of 3-hydroxybutyrate and no other abnormalities.
After the lactic acidosis was discovered, a therapeutic trial with several vitamins was started. These included thiamine (500 mg/ day), pyridoxine (250 mg/day), biotin (20 mg/day), nicotinic acid (50 mg/day), and riboflavin (50 mg/day). None seemed to ameliorate the symptoms.
Recent neurological examination was normal except for peripheral muscle weakness without atrophy. ECG and auditory evoked responses were normal. Routine visual testing and electroogulography were also normal; however, an electroretinogram was marginally abnormal and dark adaptometry showed elevated cone and rod thresholds with periodic fluctuations possibly related to retinal fatigue.
MATERIALS AND METHODS
Control and patient muscles were obtained by open biopsy after signed permission and informed consent were given. Tissue for biochemical analysis was frozen immediately and stored at -70°C. A portion of tissue for microscopy was placed in 10% formalin and a further portion was frozen for histochemistry. Tissue for electron microscopy was placed immediately in 1.5% glutaraldehyde/ 1.5 % paraformaldehyde in cacodylate buffer.
Frozen sections of muscle were examined with the modified Gomori trichrome stain (1 8) and tested for succinic dehydrogenase (34), NADH-tetrazolium reductase (I 9). and acid phosphatase (4) activities according to standard procedures.
Gas chromatography of urine organic acids. Organic acids were extracted from acidified urine into ethyl acetate, converted to trimethylsilyl derivatives, and quantitated by gas chromatography on a 10% OV-1 column according to standard procedures (27) . Peak identities were confirmed by mass spectrometry.
Tissue preparation. Muscle extracts were prepared by homogenization in 9 volumes of 0.15 M KCI, 50 mM Tris-HC1, pH 7.4, in all-glass motor-driven homogenizers. Crude muscle enzyme activities were measured in supernatants obtained after centrifugation at 1000 x g for 15 min. Free carnitine was measured in neutralized supernatants of 10% muscle homogenates precipitated with equal volumes of 10% perchloric acid after centrifugation at 27,000 x g for 15 min as described previously ( 14) .
For spectral analysis and measurement of other enzyme activities in crude mitochondrial preparations, approximately 1 g of tissue was cut into small pieces and placed in 10 ml buffer containing 0.20 M sucrose, 0.13 M NaCI, and I mM Tris-HCI, pH 7.4. This was stirred on ice for 30 min with 0.14 mg of collagenase (Sigma type VII). Samples were homogenized with a loose fitting, motor-driven, Potter-Elvehjem homogenizer and then with a tight fitting homogenizer. The solution was centrifuged at 500 x g for 10 min and the precipitate was discarded.
The supernatant was centrifuged at 8000 x g for 15 min and the crude mitochondrial pellet was suspended in the isolation buffer.
Activity measurements. Free carnitine concentrations were measured by the method of McGarry and Foster (29) except that Hepes buffer was used instead of Tris-HCI. Carnitine palmitoyl-transferase and carnitine octanoyltransferase were measured by "isotope exchange" assays (6), and carnitine acetyltransferase by a spectrophotometric procedure (28) . Other enzyme activities in crude muscle homogenates were measured as described previously ( 14) .
In mitochondrial preparations, NADH-cytochrome c reductase was determined by the method of Sottocasa et al. (41) . Two distinct enzyme systems contribute to this activity; the first, which is rotenone-insensitive, is associated with the outer mitochondrial membrane (4 I) whereas the second, which is rotenonesensitive, is associated with the inner mitochondrial membrane and functions in the electron transport chain (complexes I and 111). NADH-cytochrome c reductase, measured in the absence of rotenone, reflects the sum of these activities. Rotenone-sensitive NADH-cytochrome c reductase was obtained by subtracting the value obtained in the presence of rotenone from that obtained in the absence of rotenone.
Cytochrome c oxidase activity was measured spectrophotometrically by following the oxidation of ferrocytochrome c at 550 nm. The assay was performed in a buffer containing 0.5% Tween 80, 50 mM potassium phosphate, pH 7.0. The use of detergent allows disruption of the outer mitochondrial membrane so that optimal rates can be measured. The final concentration of ferrocytochrome c was 10 pM and that of mitochondrial protein 0.0 13 mg/ml. Rates were calculated from the plot of log (ASSo -ASSo at m) and are expressed as nanomoles cytochrome c oxidized/min/mg protein.
Succinate dehydrogenase activity was measured spectrophotometrically using 2,6-dichloroindophenol as the electron accep tor and succinate as the electron donor. The reaction was monitored at 600 nm. Mitochondria ( I mg/ml) were activated prior to assay by incubation with 40 mM succinate and then diluted to 0.035 mg/ml into the cuvette for assay. The assay buffer contained 1.5 mM KCN, 16 mM succinate, 0.0015% 2,6-dichloroindophenol, and 50 mM potassium phosphate, pH 7.0.
Succinate-cytochrome c reductase activity was measured by following the reduction of femcytochrome c at 550 nm. Additions were identical to those described for the succinate dehydrogenase activity except 2,6-dichloroindophenol was omitted. The concentration of cytochrome c in the cuvette was 13.6 pM.
ATPase activity was also monitored spectrophotometrically in the absence and presence of dicyclohexyl carbodiimide (44) . All assays were conducted at 37°C using a Beckman DU7 spectrophotometer.
Spectral analysis of cytochromes. Difference spectra of the cytochromes (dithionite reduced-oxidized) were recorded at room temperature in mitochondria solubilized in 1 % Triton X-100 in 50 mM pota ium phosphate, pH 7.4, using a Beckman f DU 7 spectrophoto eter. The concentrations of cytochromes were calculated using the extinction coefficients of Bookelman et al. (7) .
Antibody-binding experiments. Subunits of purified beef heart complex 111 were prepared by gel filtration in Bio-gel P-100 after dissociation by SDS. Purity of the fractions was judged by SDSpolyacrylamide gel electrophoresis. Antibodies were raised in rabbits against the purified components of complex 111. One preparation of anti-complex 111 antibody was the generous gift of Dr. J. Hare, Oregon Health Sciences University, Portland. SDS-polyacrylamide gels were made as described by Fuller et al. (20) and Western blots were performed as described by Towbin et a/. (46) with the addition of 0.1 % SDS to the electrophoresis buffer.
RESULTS
Muscle Histochemistry. Semithin, plastic-embedded, toluidine blue-stained sections showed muscle fibers which did not vary greatly in size or shape. The connective tissue appeared normal. There was no fiber degeneration or inflammatory infiltrates and subsarcolemmal inclusions were absent. Subserial frozen sections (Fig. 2) . The red granular material was present beneath the sarcolemma and within the more central portions of the muscle fibers. Scattered subsarcolemmal vacuoles were also noted. With both succinic dehydrogenase and NADH-tetrazolium reductase preparations, there was marked increase in the amount of reaction product within individual fibers. With Oil Red 0 , many muscle fibers contained increased amounts of lipid. In the acid phosphatase preparations, there was an increased amount of reaction product in many of the affected muscle fibers. This reaction product was not present within vacuoles.
Electron micros cop.^. Electron microscopy of muscle revealed several fibers with internally located nuclei. The myofilamentous architecture was intact, and the plasmalemmal-basal laminar complex was continuous. Some fibers contained subsarcolemmally placed collections of bizarre mitochondria (Fig. 3) . Many of these mitochondria had unusual shapes and were overly large. Others contained disrupted cristae and round or longitudinally oriented paracrystalline inclusions. Glycogen particles and lipid droplets did not appear to be increased. One terminal nerve twig was seen and was normal. Electron microscopy of peripheral blood leukocytes and cultured skin fibroblasts revealed no abnormalities.
Response to fasting and to oral medium chain triglycerides. In order to evaluate our patient's ability to generate ketone bodies, she fasted for 8-9 h and then was given an oral load of 50 ml MCT oil (mostly C6, Cs, and Clo fatty acids) and sequential 2-hr urine samples were collected. The major urinary organic acids in the fasting (preload) and 4-6-hr postload samples are shown in Table 1 . Several organic acids, notably lactate and 3-hydroxybutyrate, were greatly increased in the 8-9-hr fasting sample. Following the MCT load, lactate, 3-hydroxybutyrate, acetoacetate, and sebacate increased substantially, but the increase in adipate and suberate was low for the degree of ketosis (35) . Citrate also appeared lower than normal. Several other unusual metabolites were present in both samples, particularly fumarate, malate, 2-ketoglutarate, and 7-hydroxyoctanoate.
Biochemical Studies. The content of free carnitine in muscle from the patient was 2.08 pmol/g wet weight (controls, 2.34 + 0.87 pmol/g wet weight; n = 56). In serum, free carnitine was 27.3 rmol/ml (controls, 5 1.1 + 1 1.1 pmol/ml; n = 59). These values, along with the normal activity of carnitine palmitoyltransferase, carnitine octanoyltransferase, and carnitine acetyltransferase (Table 2 ) ruled out a defect of the carnitine acylcarnitine system in this patient. A number of other enzyme activities were also measured in crude homogenates of muscle and these are shown in Table 2 . The activity of succinate-cytochrome c reductase was diminished to about 3% of the mean control value whereas all other enzyme activities were normal or increased. Mixing experiments with control and patient tissue showed no reduction over expected values for succinate-cytochrome c reductase, indicating that the reduced activity in the patient's muscle was not due to the presence of an inhibitor.
The activities of several enzymes, measured in a mitochondrial preparation isolated from frozen muscle, are shown in Table 3 . Succinate-cytochrome c reductase activity was again strikingly diminished; succinate dehydrogenase, however, was only slightly below the control value. Rotenone-sensitive NADH-cytochrome c reductase was also undetectable in the patient compared to the controls. The normal activity of total NADH-cytochrome c reductase in crude muscle homogenate is apparently of no value in indicating a deficiency of ubiquinol-cytochrome c reductase, presumably because the loss of this activity on the inner mitochondrial membrane is masked by the normal enzyme activity associated with the outer membrane. These results indicate a (Fig. I) . Figure 4 shows the reduced-oxidized difference spectra of the cytochromes obtained from mitochondrial preparations of patient and control muscle. The characteristic absorbance maxima of cytochrome b at 428 nm in the Soret region and at 562 nm in the LY band region were greatly diminished in the patient's sample. The relative amounts of cytochromes, calculated from these spectra, are reported in Table 4 and confirm the marked deficiency of cytochrome b in the patient. In the presence of antimycin A, which inhibits electron transport at the level of cytochrome b, the concentration of cytochrome b in control muscle rose by 5 1 % whereas in the patient's muscle it fell by 33%. These data confirm the deficiency of cytochrome b in the patient and are compatible with the enzyme activity measurements reported above, indicating a defect at the level of complex I11 (Fig. I) . Complex 111 consists of 10 constituent polypeptides (8) . In order to determine which of these proteins were affected in the patient, antibody-binding experiments were performed. The mitochondrial proteins were first separated by SDS-polyacrylamide gel electrophoresis, and then transferred to nitrocellulose paper. The transferred proteins were incubated with antibodies raised in rabbits against native beef heart complex I11 dissolved in 0.1 % Triton X-100. The subunit-specific antibodies were visualized by binding fluorescein isothiocyanate-labeled goat anti-rabbit antibody. Figure 5 , lane 1, shows antibody binding to purified beef heart complex 111. It is clear that only a few of the polypeptide subunits react with antibody under these conditions. This is not unexpected since the antibody was raised against native protein in which some subunits may be masked by either detergent or by the other subunits. Under such conditions, the antigenic subunits are most likely to be exposed to the aqueous phase. This is in fact the case for core proteins 1 and 2, cytochrome c l , and subunit VI which are all exposed (5, 16) . In the patient ( These deficiencies, in addition to the low levels of reducible cytochrome b, indicate a more generalized defect of complex I11 than was evident by the spectral analysis and enzyme activity measurements alone. -45,000); c,, cytochrome c, (mol wt -30,000) ; VI, subunit VI (mol wt -16,000). 1, 2 pg purified beef heart complex 111; 2, 80 pg of mitochondrial protein from patient muscle; 3, 80 pg of mitochondrial protein from control muscle.
DISCUSSION
Our patient has suffered from slowly progressive exercise intolerance and muscle weakness since 9 years of age. Although she was noted to have a metabolic acidosis at the age of 10, lactic acidosis was not documented until several years later. This oversight should be emphasized since many physicians are not attuned to investigate minor degrees of metabolic acidosis. The absence of hypoglycemia and central nervous system signs reduced the likelihood of a defect of pyruvate carboxylase or the pyruvate dehydrogenase complex. However, the association of lactic acidosis with muscle weakness and the appearance of a typical ragged red fiber myopathy has been reported in several patients believed to have a disorder of the respiratory chain including NADH-coenzyme Q reductase deficiency (25, 26, 32, 33, 40) , cytochrome b deficiency (3 1,33,42) , and cytochrome c oxidase deficiency (14, 15, 43, 47, 49) . With the exception of cytochrome oxidase, most of these deficiencies have been deduced from spectral or oxygen consumption studies alone. However, with complexes at the beginning of the electron transfer pathway, such measurements are prone to artifact.
Measurement of enzyme activities in both crude muscle homogenates and in mitochondrial preparations revealed deficient activity of succinate-cytochrome c reductase in our patient. Normal activity of succinate dehydrogenase with DCIP as an electron acceptor and lack of detectable rotenone-sensitive NADH-cytochrome c reductase activity in the patient indicate the defect is at the level of ubiquinol-cytochrome c reductase. The spectral analysis of cytochromes in mitochondrial preparations of muscle revealed a striking deficiency of reducible cytochrome b in the patient. Since cytochrome b is a constituent of complex 111, this is consistent with the results discussed above. Two types of cytochrome b with different redox potential are present in complex 111 (36) . In the spectra shown here, the two forms are not distinguishable. Since only one mitochondrial structural gene appears to code for apocytochrome b, the spectroscopic differences are probably induced after synthesis and integration into complex 111.
Deficiency of cytochrome b has previously been reported in four patients. Two of these, a father and son, presented with progressive ataxia, muscle weakness, insidious dementia, and other findings which suggested a spinocerebellar degenerative disorder (42) . Respiration of mitochondria was 25-30% of normal with glutamate plus malate or with succinate and was insensitive to the action of antimycin A, suggesting a defect of respiration at the level of cytochrome b. Cytochrome b levels in the two patients were 24 and 44% of normal, respectively. Cytochrome a was also reduced to approximately 50% of normal. Morgan-Hughes and co-workers have described two additional unrelated patients with apparent deficiency of cytochrome b (3 1, 33). Clinically, the first patient was similar to our patient, with slowly progressive muscle weakness and fatiguability, whereas the second patient had CNS dysfunction with involuntary jerking movements, ataxia, disorientation, confusion, paranoia, mild deafness, and visual impairment in addition to muscle weakness. Both patients had ragged red fiber myopathy; elevated lactate concentrations were reported in urine of the first case and in blood of the second. In both patients, respiratory rates were low with pyruvate plus malate or with succinate, and the content of cytochrome b was diminished. In none of these four patients with cytochrome b deficiency were the activities of succinatecytochrome c reductase or NADH-cytochrome c reductase measured. However, a defect of ubiquinol-cytochrome c reductase could be inferred from the oxygen consumption and spectral studies.
The data reported for our patient have demonstrated, for the first time, a specific deficiency of ubiquinol-cytochrome c reductase or complex 111 activity of human mitochondrial inner membrane. Complex 111 is a multicomponent protein composed of 10 distinct polypeptides (8) . These include core proteins 1 and 2, a nonheme Fe-S center, cytochrome b, cytochrome c,, and five additional polypeptides. For the antibody-binding studies, antibodies were raised against native purified complex 111 from beef heart; these cross-react with human complex 111 as shown in Figure 5 (lane 3) . This is not unexpected since the mitochondrial electron transfer proteins are highly conserved (1, 12). Only three bands were resolved in these preparations, representing cross-reaction with four proteins (core proteins 1 and 2 comigrate under these electrophoretic conditions). The other proteins of complex 111 may not elicit antibody in this preparation because of shielding by other protein subunits or detergent. Deficiencies in core proteins 1 and 2 as well as subunit VI are evident in the patient's sample. Cytochrome c, appeared to be present in normal amount and this is consistent with the normal concentration of cytochrome c + cl measured spectrally. We have no information on the presence or absence of the other subunits of complex 111. Thus, the lesion extends to at least four polypeptides of complex I11 and is not restricted to reducible cytochrome b.
It is known that cytochrome b is coded for by mitochondrial DNA whereas the other nine peptides of complex 111 are coded for by nuclear DNA (I). The nature of the primary defect which gives rise to deficiency of several polypeptides, coded for by both nuclear and mitochondrial DNA is not known. Further antibodybinding experiments have been undertaken to define more precisely the extent of the abnormality of mitochondrial inner membrane components in this patient and these are reported elsewhere ( 10) .
There are several puzzling features of the clinical presentation of this patient and others with similar defects of electron transport. In particular, it is unclear why muscles, and possibly the retina, seem to be the only tissues affected. There is no clinical evidence for liver or kidney involvement; liver function tests are normal and there is no Fanconi syndrome. However, the urinary organic acid excretion patterns following fasting and the response to an MCT load may be relevant to this question. If the defect in complex 111 occurred in the liver, then one might expect to see poor p-oxidation of fatty acids which usually results in woxidation with urinary excretion of dicarboxylic acids. By contrast, the degree of ketoacidosis in the fasting sample was excessive for only 8-9 h of fasting in an adult, whereas thedicarboxylic acids, adipic and suberic, were relatively much reduced for the degree of ketosis. In addition, the P-hydroxybutyratelacetoacetate ratio was abnormally high, presumably reflecting an increased mitochondrial NADHINAD ratio (50) . This might also explain the low level of citrate, secondary to reduced oxaloacetate production from malate via NAD-dependent dehydrogenation. The presence of several citric acid cycle metabolites, particularly fumarate and malate, has been reported in other patients with primary lactic acidosis (8, 40) . Whether these derive from faulty renal metabolism or are filtered from the blood is not clear. Finally, the presence of 7-hydroxyoctanoic acid in the fasting urine sample is unusual. This product of w-1 oxidation has been reported in patients with defects of mitochondrial boxidation (9) but its significance in this case is not clear. Following the MCT load, urine lactate and 3-hydroxybutyrate rose dramatically, the P-hydroxybutyratelacetoacetate ratio remained abnormally high, and the increase in dicarboxylic acid excretion was lower than in control subjects. The undetectable level of citrate in the postload urine suggests a further depression of oxaloacetate production from malate because of a worsening redox state and/ or reduced generation from other sources such as aspartate or pyruvate. Although these results provide no evidence for a block in fatty acid P-oxidation, as might have been expected from the deficiencies of complex 111, they do suggest a deranged energy metabolism in liver and/or kidney, which can largely be explained by a relative deficiency of NAD.
Another puzzling aspect of our patient's presentation is that there were no symptoms until 9 years of age although she was fully active until that time. The increasing disability over the past few years implies that the disorder is progressive and suggests that there may be differences in the regulation of the respiratory components in different tissues and at different ages. However, with the present data, we cannot distinguish between a regulatory or structural gene defect, or even rule out the possibility of some outside environmental agent in the etiology of this condition. The answer to these questions awaits further understanding of the control of expression of the various components of the respiratory chain in different tissues and the nature of the primary defect in these patients.
